Treating morbid obesity with laparoscopic adjustable gastric banding

American Journal of Surgery

Volumn 194, Issue 3, 2007, Pages 333-343

  Martin, Louis F ^a   Smits, Gerard J ^b   Greenstein, Robert J ^c  

^a LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^b Computer and Consulting Statisticians Inc ^*  (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Adjustable gastric banding; Clinical trials; LAP BAND; Laparoscopy; Morbid (severe) obesity; Quality of life; Restrictive bariatric surgery; Safety; Weight loss

Indexed keywords

ARTICLE; BODY MASS; CLINICAL TRIAL; COMORBIDITY; DEVICE; FOOD INTAKE; GASTRIC BANDING; GASTROINTESTINAL SYMPTOM; HEALTH CARE ORGANIZATION; HUMAN; MORBID OBESITY; MORTALITY; PRIORITY JOURNAL; QUALITY OF LIFE; REOPERATION; SURGICAL TECHNIQUE; WEIGHT REDUCTION;

ADULT; FEMALE; GASTROPLASTY; HUMANS; LAPAROSCOPY; MALE; OBESITY, MORBID; PROSPECTIVE STUDIES;

EID: 34547650736     PISSN: 00029610     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjsurg.2007.03.002     Document Type: Article

References (61)

1. Flegal K.M., Carroll M.D., Ogden C.L., et al. Prevalence and trends in obesity among US adults, 1999-2000. JAMA 288 (2002) 1723-1727
2. Prevalence of Overweight and Obesity Among Adults: United States, 1999 (initial results). National Health and Nutrition Examination Survey 1999 (NHANES 1999). Oct. 24, 2002. Available at: http://www.cdc.gov/nchs/products/pubs/pubd/hestats/obese/obse99.htm. Accessed January 13, 2004.
3. Doll S., Paccaud F., Bovet P., et al. Body mass index, abdominal adiposity and blood pressure: consistency of their association across developing and developed countries. Int J Obes Relat Metab Disord 26 (2002) 48-57
4. Friedrich M.J. Epidemic of obesity expands its spread to developing countries. JAMA 287 (2002) 1382-1386
5. Detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III). Third Report of the National Cholesterol Education Program (NCEP) Expert Panel: NHLBI of the NIH (2001), National Institutes of Health, Bethesda, MD May. National Institutes of Health No. 01-3670
6. National Institutes of Health. Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults-the evidence report. Obes Res 2 suppl 6 (1998) 51S-209S
7. Obesity: preventing and managing the global epidemic. Report of a WHO Consultation on Obesity (1998), World Health Organization, Geneva, Switzerland Report No. NUT/NCD/98.1
8. Pi-Sunyer F.X. Medical hazards of obesity. Ann Intern Med 119 (1993) 655-660
9. Mokdad A.H., Ford E.S., Bowman B.A., et al. Prevalence of obesity, diabetes and obesity-related health risk factors. JAMA 289 (2002) 76-79
10. Stunkard A.J., Stinnett J.L., and Smoller J.W. Psychological and social aspects of the surgical treatment of obesity. Am J Psychiatry 143 (1986) 417-429
11. Fontaine K.R., Redden D.T., Wang C., et al. Years of life lost due to obesity. JAMA 289 (2003) 187-193
12. Wolf A.M., and Colditz G.A. Current estimates of the economic cost of obesity in the United States. Obes Res 6 (1998) 97-106
13. Committee to Develop Criteria for Evaluating the Outcomes of Approaches to Prevent and Treat Obesity, Institute of Medicine. Weighing the Options: Criteria for Evaluating Weight Management Programs (1995), National Academy Press, Washington DC
14. Guidance for the Clinical Evaluation of Weight Control Drugs (1996), Division of Metabolic and Endocrine Drug Products, Food and Drug Administration, Rockville, MD (9-24-1996)
15. Wing R.R., Venditti E., Jakicic J.M., et al. Lifestyle intervention in overweight individuals with a family history of diabetes. Diabetes Care 21 (1998) 350-359
16. Lean M.E. Sibutramine-a review of clinical efficacy. Int J Obes Relat Metab Disord 21 suppl 1 (1997) S30-S39
17. Wadden T.A., Berkowitz R.I., Sarwer D.B., et al. Benefits of lifestyle modification in the pharmacologic treatment of obesity: a randomized trial. Arch Intern Med 161 (2001) 218-227
18. Davidson M.H., Hauptman J., DiGirolamo M., et al. Weight control and risk factor reduction in obese subjects treated for 2 years with orlistat: a randomized controlled trial. JAMA 281 (1999) 235-242
19. James W.P., Astrup A., Finer N., et al. Effect of sibutramine on weight maintenance after weight loss: a randomized trial. STORM Study Group. Sibutramine Trial of Obesity Reduction and Maintenance. Lancet 356 (2000) 2119-2125
20. Gastrointestinal surgery for severe obesity: National Institutes of Health Consensus Development Conference Statement. Am J Clin Nutr 55 2 suppl (1992) 615S-619S
21. Mason E.E., and Ito C. Gastric bypass. Ann Surg 170 (1969) 329-336
22. Mason E.E. Vertical banded gastroplasty for obesity. Arch Surg 117 (1982) 701-706
23. Hess D.S., and Hess D.W. Biliopancreatic diversion with a duodenal switch. Obes Surg 8 (1998) 267-282
24. Andersen T., Backer O.G., Stokholm K.H., et al. Randomized trial of diet and gastroplasty compared with diet alone in morbid obesity. N Engl J Med 310 (1984) 352-356
25. Sjostrom L., Larsson B., Backman L., et al. Swedish obese subjects (SOS). Recruitment for an intervention study and a selected description of the obese state. Int J Obes Relat Metab Disord 16 (1992) 465-479
26. Mason E.E., Renquist K.E., and Jiang D. Perioperative risks and safety of surgery for severe obesity. Am J Clin Nutr 55 2 suppl (1992) 573S-576S
27. Martin L.F., White S., and Lindstrom Jr. W. Cost-benefit analysis for the treatment of severe obesity. World J Surg 22 (1998) 1008-1017
28. Belachew M., Legrand M.J., and Vincent V. History of Lap-Band: from dream to reality. Obes Surg 11 (2001) 297-302
29. Scopinaro N. The IFSO and obesity surgery throughout the world. International Federation for the Surgery of Obesity. Obes Surg 8 (1998) 3-8
30. Build Study (1983), Society of Actuaries and Association of Life Insurance Medical Directors of America Statistical Bulletin, Chicago, Illinois Jan-Jun
31. O'Brien P.E., Brown W.A., Smith A., et al. Prospective study of a laparoscopically placed, adjustable gastric band in the treatment of morbid obesity. Br J Surg 86 (1999) 113-118
32. Deitel M., and Greenstein R.J. Recommendations for reporting weight loss. [editorial]. Obes Surg 13 (2003) 159-160
33. Kuczmarski R.J., and Flegal K.M. Criteria for definition of overweight in transition: background and recommendations for the United States. Am J Clin Nutr 72 (2000) 1074-1081
34. Beck A.T., and Steer R.T. Manual for the Beck Depression Inventory (1993), Psychological Corporation, San Antonio, TX
35. Cash T.F. Body-image attitudes among obese enrollees in a commercial weight-loss program. Percept Mot Skills 77 (1993) 1099-1103
36. Ware Jr. J.E., and Sherbourne C.D. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 30 (1992) 473-483
37. Kuzmak L.I. A review of seven years' experience with silicone gastric banding. Obes Surg 1 (1991) 403-408
38. Diggle P.J., Heagerty P., Liang K.-Y., et al. Analysis of Longitudinal Data. 2nd ed. Vol. 1 (2002), Oxford University Press, New York, NY
39. Horng S., and Miller F.G. Is placebo surgery unethical?. N Engl J Med 347 (2002) 137-139
40. Sugerman H.J., Starkey J.V., and Birkenhauer R. A randomized prospective trial of gastric-bypass versus vertical-banded-gastroplasty for morbid-obesity and their effects on sweet-eaters versus non-sweet-eaters. Ann Surg 205 (1987) 613-622
41. Moseley J.B., O'Malley K., Petersen N.J., et al. A controlled trial of arthroscopic surgery for osteoarthritis of the knee. N Engl J Med 347 (2002) 81-88
42. Pich J., Carne X., Arnaiz J.A., et al. Role of a research ethics committee in follow-up and publication of results. Lancet 361 (2003) 1015-1016
43. Antes G., and Chalmers I. Under-reporting of clinical trials is unethical. Lancet 361 (2003) 978-979
44. Mann H. Research ethics committees and public dissemination of clinical trial results. Lancet 360 (2002) 406-408
45. Doherty C., Maher J.W., and Heitshusen D.S. Long-term data indicate a progressive loss in efficacy of adjustable silicone gastric banding for the surgical treatment of morbid obesity. Surgery 132 (2002) 724-728
46. DeMaria E.J., Sugerman H.J., Meador J.G., et al. High failure rate after laparoscopic adjustable silicone gastric banding for treatment of morbid obesity. Ann Surg 233 (2001) 809-818
47. Kellum J.M. Gastric banding. Ann Surg 237 (2003) 17-18
48. Forsell P., Hallerback B., Glise H., et al. Complications following Swedish adjustable gastric banding: a long-term follow-up. Obes Surg 9 (1999) 11-16
49. Angrisani L., Alkilani M., Basso N., et al. Laparoscopic Italian experience with the Lap-Band. Obes Surg 11 (2001) 307-310
50. Allen J.W., Coleman M.G., and Fielding G.A. Lessons learned from laparoscopic gastric banding for morbid obesity. Am J Surg 182 (2001) 10-14
51. Dargent J. Laparoscopic adjustable gastric banding: lessons from the first 500 patients in a single institution. Obes Surg 9 (1999) 446-452
52. Pories W.J., MacDonald Jr. K.G., Morgan E.J., et al. Surgical treatment of obesity and its effect on diabetes: 10-y follow-up. Am J Clin Nutr 55 2 suppl (1992) 582S-585S
53. Christou N.V., Sampalis J.S., Liberman M., et al. Surgery decreases long-term mortality, morbidity, and health care use in morbidly obese patients. Ann Surg 240 (2004) 416-424
54. Flum D.R., and Dellinger E.P. Impact of gastric bypass operation on survival: a population-based analysis. J Am Coll Surg 199 (2004) 543-551
55. Flum D.R., Koepsell T., Heagerty P., et al. The nationwide frequency of major adverse outcomes in antireflux surgery and the role of surgeon experience, 1992-1997. J Am Coll Surg 195 (2002) 611-618
56. Flum D.R., Koepsell T., Heagerty P., et al. Common bile duct injury during laparoscopic cholecystectomy and the use of intraoperative cholangiography: adverse outcome or preventable error?. Arch Surg 136 (2001) 1287-1292
57. Martin L.F. The biopsychosocial characteristics of people seeking treatment for obesity. Obes Surg 9 (1999) 235-243
58. Dixon J.B., Dixon M.E., and O'Brien P.E. Quality of life after Lap-Band placement: influence of time, weight loss, and comorbidities. Obes Res 9 (2001) 713-721
59. Peppelenbosch N., Buth J., Harris P.L., et al. Diameter of abdominal aortic aneurysm and outcome of endovascular aneurysm repair: does size matter?. A report from EUROSTAR. J Vasc Surg 39 (2004) 288-297
60. Greenstein R.J., Nissan A., and Jaffin B.W. Esophageal anatomy and function in laparoscopic gastric restrictive bariatric surgery: implications for patient selection. Obes Surg 8 (1998) 199-206
61. Jaffin B.W., Knoepflmacher P., and Greenstein R.J. High prevalence of asymptomatic esophageal motility disorders among morbidly obese patients. Obes Surg 9 (1999) 390-395 The results of the US Food and Drug Administration monitored premarket approval trial of the first adjustable gastric band approved for use in the United States as a surgical treatment for morbid obesity and its co-morbid medical conditions are presented.